THE TREND
(Boursier.com) — After 10% gains since the start of the year and an upward acceleration yesterday in the wake of central bank announcements, the CAC40 is logically taking a break this Friday. The drop is however very limited at the end of the morning: -0.3% to 7,145 points.
If the Nasdaq again regained more than 3% last night thanks to Meta’s spectacular jump of 23% after its accounts, the trend is expected to be more uncertain also across the Atlantic in the wake of the triple publication of Apple, Google and Apple. Amazon (significantly) worse than expected last night…
In addition, the market is now awaiting the US Department of Labor’s employment report this afternoon. The market consensus predicts a slowdown in job creations to 185,000 in January, a deceleration in the rise in the average hourly wage to 4.3% over one year and an unemployment rate of 3.6%.
RISING VALUES
* Publicis gains even more than 3% to 73.1 euros. Barclays went back from ‘online weighting’ to ‘overweight’ by targeting a course of 85 euros.
* GTT (+2%) obtained a grant of 4.66 million euros from Bpifrance as part of the MerVent 2025 project, winner of the “CORIMER 2022” call for expressions of interest. The project concerns the design of a CO2 capture system on board ships.
* Ubisoft resumed 1.5% to 20.87 euros. The title had rebounded by around 10% yesterday at the end of the session in Paris. Guillemot Brothers Limited has announced that it has agreed on January 31 to settle in cash and in advance the transaction concluded with a bank on September 5, 2016 and relating to the acquisition by Guillemot Brothers Limited of 4,000,008 Ubisoft Entertainment SA shares. This settlement is made exclusively in cash. It is recalled that the shares forming the subject of the acquisition agreement were pledged in favor of the bank, which could borrow them from Guillemot Brothers Limited under certain conditions provided for in the related pledge agreement. As part of the transaction, this borrowing mechanism is terminated. It is also planned to release this pledge when the transaction is concluded (anticipated around mid-2023). Guillemot Brothers Limited will then have full economic ownership of these shares.
FALLING VALUES
* Sanofi fell 2.7% to 84.5 euros after warning that its profit growth will slow this year. The laboratory expects net earnings per share growth from its activities in 2023 in the low single-digit range at constant exchange rates, compared to an increase of 25.9% in 2022. exchange rates on 2023 business EPS is estimated at around -3.5% to -4.5% by applying average January exchange rates, Sanofi said. 2022 sales increased by 13.9% to 43 billion euros, supported by Dupixent (+43.8% to 8.293 billion euros), whose sales increased by 3 billion euros, the performance of Vaccines (+6 .3%) in line with the medium-term objectives and the execution of the Consumer Health strategy (+8.6%). Free cash flow reached 8.48 billion euros (+4.8%).
* Capgemini fell 1.4% to 185.7 euros at the end of the week, after three good upward sessions including a jump of more than 6% on Thursday. In a note dedicated to the SSII, Oddo BHF explains that market sentiment seems excessively negative. Since the publication of Q3 sales in October, Capgemini has significantly underperformed its benchmark indices. The broker thus reiterates its ‘outperform’ opinion with an adjusted target of 216 to 218 euros.
* Orpea sinks further 15% to 3.18 euros after a low in session of 2.63 euros. Short selling appears to be stoking volatility pending recapitalization.